• HyperScript™ Reverse Transcriptase for RNA Workflows

  2026-08-18

  Build more reliable cDNA from structured, scarce, or long RNA templates with a thermally stable, RNase H-reduced reverse transcriptase. This practical guide connects HyperScript™ Reverse Transcriptase to qPCR workflows, hepatocellular carcinoma research, and troubleshooting decisions that improve assay consistency.

• Annexin V-Cy5/DAPI Apoptosis Kit Workflow

  2026-08-17

  Build a rapid, dual-parameter workflow for separating viable, apoptotic, and necrotic cells in drug-response experiments. This guide translates the P2RX1–CaMKII–PI3K/Akt findings in Ph+ ALL into practical assay design, controls, and troubleshooting using the Annexin V-Cy5/DAPI Apoptosis Kit.

• Machine Learning for Senolytic Discovery

  2026-08-17

  The 2023 Nature Communications study presents a data-efficient machine-learning strategy for finding senolytics from published screening data rather than relying on large proprietary datasets. Its experimental validation identified ginkgetin, periplocin, and oleandrin as active senolytic candidates in human cell models, while also illustrating the opportunities and limitations of computational prioritization.

• CHIR-99021: From Wnt Control to Assay Design

  2026-08-16

  CHIR-99021 (CT99021) is more than a Wnt-pathway reagent: it can serve as a precise perturbation tool for separating signaling, differentiation, and genome-organization phenotypes. This guide connects GSK-3 inhibition with modern assay design and the latest loop-extrusion research.

• Red Blood Cell Membrane Bending Rigidity

  2026-08-15

  Himbert and colleagues isolated the bending response of the red blood cell cytoplasmic membrane from the mechanical contribution of the spectrin network. By combining X-ray diffuse scattering, neutron spin-echo spectroscopy, and molecular dynamics simulations, they estimated a relatively low bending modulus of approximately 4–6 kBT and clarified why whole-cell measurements span a much wider range.

• Forskolin in Human Neuron Reactivation Assays

  2026-08-14

  Forskolin is an adenylate cyclase activator that provides a controllable cAMP stimulus for human sensory-neuron models. This article explains how the compound supports HSV-1 latency and reactivation assays while distinguishing assay utility from therapeutic interpretation.

• MAPK10–KRT16 Signaling in NSCLC Metastasis

  2026-08-14

  The reference study identifies MAPK10 as a metastasis-suppressive kinase that phosphorylates KRT16 at Ser356 and Ser397, enabling RNF213-mediated ubiquitination and proteasomal degradation. Its combination of cell, mouse, and clinical evidence positions the MAPK10/KRT16/RNF213 axis as a mechanistic framework for NSCLC prognosis and future therapeutic investigation.

• FLCN mRNA Rescue in Birt-Hogg-Dubé Syndrome

  2026-08-13

  A 2026 study identified the rare FLCN variants p.W376R and p.Q44* in two Chinese Birt-Hogg-Dubé syndrome families and combined segregation, molecular, and cell-based evidence to assess their pathogenicity. Exogenous FLCN mRNA restored protein expression and normalized mTORC1 dysregulation in HEK293T cells, providing an important but preliminary foundation for RNA-based protein replacement research.

• Cholesterol for Membrane and LNP Research

  2026-08-13

  Use Cholesterol as a controllable membrane variable for fluidity assays, lipid metabolism research, and lipid nanoparticle development. This workflow connects bench-scale solubility and formulation control with the localized p21 mRNA–LNP strategy reported for bladder cancer, while clearly separating validated findings from practical optimization recommendations.

• P2RX1 and Mitochondrial Apoptosis in Ph+ ALL

  2026-08-12

  Li et al. identify P2RX1 as a regulator of tyrosine kinase inhibitor-associated mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia, linking calcium dysregulation and CaMKII activation to PI3K/Akt suppression. The findings provide a mechanistic framework for studying treatment response, while also highlighting the need for validation in primary leukemia models and clinical samples.

• Dibutyryl-cAMP, sodium salt in Cell Signaling

  2026-08-12

  Dibutyryl-cAMP, sodium salt provides a practical way to perturb intracellular cAMP, PKA-linked signaling, inflammation models, and neuronal reprogramming workflows. This guide translates the compound’s stable, cell-permeable behavior into dose-finding, time-course, assay-design, and troubleshooting strategies.

• Affordable GRO-seq Profiling in Bread Wheat

  2026-08-11

  This STAR Protocols paper presents a lower-cost Global Run-On sequencing workflow for measuring nascent transcription in allohexaploid bread wheat. Its central innovation is rRNA depletion after nuclear RNA isolation and before nascent RNA immunoprecipitation, which increased the proportion of valid sequencing data by 20 times in the reported application.

• From Modified UTP to Translational mRNA

  2026-08-11

  A strategic guide to using N1-Methyl-Pseudouridine-5'-Triphosphate in RNA synthesis and translational research, connecting molecular design with the emerging evidence for co-encapsulated antigen and adjuvant mRNA vaccines.

• PAD4-IN-2 TFA: Tumor-Targeted PAD4 Workflows

  2026-08-10

  PAD4-IN-2 TFA, also known as Compound 5i TFA, is designed to connect tumor-directed uptake with inhibition of PAD4-driven H3cit and NET biology. This guide translates the published mechanism into practical biochemical, cellular, immune-microenvironment, and metastasis research workflows, with troubleshooting strategies for separating direct tumor effects from neutrophil-mediated responses.

• VX-661: A Proteostasis-Aware CFTR Assay Guide

  2026-08-09

  VX-661 is a F508del CFTR corrector that helps restore mutant-protein trafficking and CFTR-mediated chloride channel activity. This guide explains how calnexin-dependent proteostasis, treatment sequence, and orthogonal readouts can improve cystic fibrosis research decisions.

556 records 8/38 page Previous Next First page 上5页 678910 下5页 Last page